FDA proposes mammogram changes for first time in 20 years to identify breast cancer early

The U.S. Food and Drug Administration proposed new rules Wednesday that will require mammogram centers to tell women more about how dense breast tissue can affect their health and increase their cancer risk. The proposal aims to identify breast cancer risks earlier, amending regulations under the Mammography Quality Standards Act of 1992. "The new proposed rule on mammography will require, for the first time under federal rules, that women receive information about breast density to better inform their healthcare decisions," FDA Commissioner Scott Gottlieb said in a statement. Read the full article HERE

Eisai, Biogen move Alzheimer’s treatment into Phase III

Eisai and Biogen have announced that a Phase III trial has been initiated for the anti-amyloid beta protofibril antibody BAN2401, for use in patients with early Alzheimer's disease. The news comes just days after the companies stopped two global Phase III trials of its previous Alzheimer's drug, aducanumab, after interim analyses indicated that the agent was ineffective and would not meet the primary endpoint. Read th3 full article HERE

NYU open-sources breast cancer screening model trained on over 200,000 mammography exams

Breast cancer is the second leading cancer-related cause of death among women in the U.S. It’s estimated that in 2015, 232,000 women were diagnosed with the disease and approximately 40,000 died from it. And while diagnostic exams like mammography have come into wide practice — in 2014, over 39 million breast cancer screenings were performed in the U.S. alone — they’re not always reliable. About 10 to 15 percent of women who undergo a mammogram are asked to return following an inconclusive analysis. Read the full article HERE

Is It Alzheimer's Or Another Dementia? The Right Answer Matters

In the U.S., older people with dementia are usually told they have Alzheimer's disease. But a range of other brain diseases can also impair thinking and memory and judgment, according to scientists attending a summit on dementias held Thursday and Friday at the National Institutes of Health. These include strokes, a form of Parkinson's disease and a disease that damages brain areas that regulate emotion and behavior. Read the full article HERE

New Study Says Breast Cancer Is 11 Different Diseases, Allowing Researchers To Predict Relapse

New research published in the journal Nature shows that breast cancer is 11 genetically distinct diseases, and each has a different prognosis and chance of coming back after treatment. “Treatments for breast cancer have improved dramatically in recent years, but unfortunately for some women, their breast cancer returns and spreads, becoming incurable. For some, this can be many years later – but it’s been impossible to accurately predict who is at risk of recurrence and who is all clear," said Carlos Caldas, professor of cancer medicine at the Cancer Research UK Cambridge Institute and leader of the study. Read the full article HERE

Eye scan can reveal changes associated with Alzheimer’s disease

Ophthalmologists at Duke University have found that a special type of eye scan can pick up changes indicative of Alzheimer’s disease. Their results were published Monday in the journal Ophthalmology Retina. The eye scan is called optical coherence tomographic angiography, or OCTA for short. Within less than a minute, OCTA takes a non-invasive picture of the retina -- the nerve cells in the back of our eyes that convert light from the outside world into nerve signals that the brain interprets into images. Read the full article HERE

Breast cancer awareness in focus in the UAE

east cancer is the fifth leading cause of death worldwide according to the World Health Organization. The MENA region, and some countries in South Asia, have the highest annual diagnosis rates worldwide, mainly due to population growth and longer life expectancy. reast cancer is the most common non-skin related malignancy in women living in GCC countries, according to reports from the US National Library of Medicine. A 2018 report also identified that Arab patients with breast cancer showed advanced stages of malignancy at the time of diagnosis and at younger ages, compared to women in Western countries. Read the full article HERE

Training Artificial Intelligence to Predict Alzheimer’s Disease

As many as one in five people age 65 or older experience “mild cognitive impairment” — a condition marked by a slight decline in memory, language, or thought. Affected individuals may be prone to forgetting appointments or losing the thread of conversations. They also have a higher-than-average risk of developing the more pronounced cognitive decline of Alzheimer’s disease. Yet for the majority of people, symptoms do not progress. In fact, in some instances, the symptoms can be temporary or reversible. Read the full article HERE

FDA warns against using surgical robots for breast cancer surgery

The FDA warned patients and health care providers Thursday about using robotically assisted surgical devices for mastectomies and other cancer surgeries because of "preliminary" evidence that it may be linked to lower long-term survival. The FDA's official safety communication said that while robotic "surgery may help reduce pain, blood loss, scarring, infection, and recovery time," there is "limited, preliminary evidence" that using the devices for cancers that affect women, specifically breast and cervical cancer, may be associated with diminished long-term survival. Read the full article HERE

Featured Posts
Recent Posts
Search By Tags
RSS Feed
  • Facebook - White Circle
  • Twitter - White Circle
  • Instagram - White Circle
  • LinkedIn - White Circle

Connect with us on social media

© 2020 Care For A Cure, Inc. is a non-profit organization

with a 501(c)(3) tax exempt status. All rights reserved.